| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Vasopressin V2 receptor |
|---|
| Ligand | BDBM521146 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Cellular In Vitro Assay for Determining Vasopressin Receptor Activity |
|---|
| IC50 | 57.0±n/a nM |
|---|
| Citation |  Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H Substituted triazole derivatives and uses thereof US Patent US11149023 Publication Date 10/19/2021 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Vasopressin V2 receptor |
|---|
| Name: | Vasopressin V2 receptor |
|---|
| Synonyms: | ADHR | AVPR V2 | AVPR2 | Antidiuretic hormone receptor | DIR | DIR3 | Renal-type arginine vasopressin receptor | V2R | V2R_HUMAN | VASOPRESSIN V2 | Vasopressin V2 receptor | Vasopressin receptor |
|---|
| Type: | Receptor |
|---|
| Mol. Mass.: | 40295.28 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P30518 |
|---|
| Residue: | 371 |
|---|
| Sequence: | MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLA
ALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQM
VGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQ
RNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGP
SERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEA
PLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTT
ASSSLAKDTSS
|
|
|
|---|
| BDBM521146 |
|---|
| n/a |
|---|
| Name | BDBM521146 |
|---|
| Synonyms: | N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-1-(trifluoromethyl)cyclopropane-carboxamide (Racemate) | US11149023, Example 41 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C24H18Cl2F6N8O2 |
|---|
| Mol. Mass. | 635.349 |
|---|
| SMILES | FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)NC(=O)C1(CC1)C(F)(F)F |
|---|
| Structure | 
|
|---|
Search and Browse
